Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1)
L1TD1 - a prognostic marker for colon cancer
Julkaisun tekijät: Deepankar Chakroborty, Maheswara Reddy Emani, Riku Klén, Camilla Böckelman, Jaana Hagström, Caj Haglund, Ari Ristimäki, Riitta Lahesmaa, Laura L. Elo
Kustantaja: BMC Cancer
Julkaisuvuosi: 2019
Journal: BMC Cancer
Volyymi: 19
Aloitussivu: 727
Sivujen määrä: 9
ISSN: 1471-2407
eISSN: 1471-2407
DOI: http://dx.doi.org/10.1186/s12885-019-5952-2
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/41079682
Background
Prognostic markers specific to a particular cancer type can assist in the evaluation of survival probability of patients and help clinicians to assess the available treatment modalities.
MethodsGene expression data was analyzed from three independent colon cancer microarray gene expression data sets (N = 1052). Survival analysis was performed for the three data sets, stratified by the expression level of the LINE-1 type transposase domain containing 1 (L1TD1). Correlation analysis was performed to investigate the role of the interactome of L1TD1 in colon cancer patients.
ResultsWe found L1TD1 as a novel positive prognostic marker for colon cancer. Increased expression of L1TD1 associated with longer disease-free survival in all the three data sets. Our results were in contrast to a previous study on medulloblastoma, where high expression of L1TD1 was linked with poor prognosis. Notably, in medulloblastoma L1TD1 was co-expressed with its interaction partners, whereas our analysis revealed lack of co-expression of L1TD1 with its interaction partners in colon cancer.
ConclusionsOur results identify increased expression of L1TD1 as a prognostic marker predicting longer disease-free survival in colon cancer patients.
Ladattava julkaisu This is an electronic reprint of the original article. |  |
